Literature DB >> 11755639

PTEN mutations and proteus syndrome.

C Eng, H Thiele, X P Zhou, R J Gorlin, R C Hennekam, R M Winter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11755639     DOI： 10.1016/S0140-6736(01)07110-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.

Authors:  Joanne Ngeow; Jessica Mester; Lisa A Rybicki; Ying Ni; Mira Milas; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.

Authors:  Min-Han Tan; Jessica Mester; Charissa Peterson; Yiran Yang; Jin-Lian Chen; Lisa A Rybicki; Kresimira Milas; Holly Pederson; Berna Remzi; Mohammed S Orloff; Charis Eng
Journal:  Am J Hum Genet       Date:  2010-12-30       Impact factor: 11.025

3.  Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.

Authors:  Joanne Ngeow; Ying Ni; Rita Tohme; Fu Song Chen; Gurkan Bebek; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

4.  Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.

Authors:  Haider Mahdi; Jessica L Mester; Emily A Nizialek; Joanne Ngeow; Chad Michener; Charis Eng
Journal:  Cancer       Date:  2014-11-05       Impact factor: 6.860

5.  Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.

Authors:  Joanne Ngeow; Kim Stanuch; Jessica L Mester; Jill S Barnholtz-Sloan; Charis Eng
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

6.  Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.

Authors:  Joanne Ngeow; Xin He; Jessica L Mester; Junying Lei; Todd Romigh; Mohammed S Orloff; Mira Milas; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2012-10-12       Impact factor: 5.958

7.  Nuclear PTEN levels and G2 progression in melanoma cells.

Authors:  Abraham I Jacob; Todd Romigh; Kristin A Waite; Charis Eng
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

8.  Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.

Authors:  Zhixiang Wu; Jessica B Doondeea; Amin Moghaddas Gholami; Melanie C Janning; Simone Lemeer; Karl Kramer; Suzanne A Eccles; Susanne M Gollin; Reidar Grenman; Axel Walch; Stephan M Feller; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2011-09-28       Impact factor: 5.911

9.  Proteus syndrome: a case report and a case study review in China.

Authors:  Xi-Bao Zhang; Chang-Xing Li; Yu-Qing He; San-Quan Zhang; Yan-Xia Cai
Journal:  Dermatol Reports       Date:  2010-02-10

Review 10.  Role of APC and DNA mismatch repair genes in the development of colorectal cancers.

Authors:  Satya Narayan; Deodutta Roy
Journal:  Mol Cancer       Date:  2003-12-12       Impact factor: 27.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.